RESUMO
Anti-aging in dermatology primarily focuses on the prevention of skin aging with UV protection (clothing and sunsceens), free radical scavengers (synthetic or botanic), and cell-protecting agents such as vitamin B3. For the correction of signs of early skin aging, retinoic acid derivatives in dermatological prescriptions are the best studied substances. Topical hormonal prescriptions are also an option if UV damage has not been the leading culprit for aging. Chemical peeling leads to a marked increase in collagen formation, the deaper the better. Ingredients in cream preparations can reduce superficial skin folds (polyphenols, amino acid peptides). Modulators of regular pigmentation are important for anti-aging preparations. Growth factors (plant extracts, recombinant growth factors) are not thoroughly studied regarding the cost-benefit and risk ratio. Complex precedures such as photodynamic therapy have an impact on the appearance of aged skin.
Assuntos
Hormônios/administração & dosagem , Ceratolíticos/administração & dosagem , Fotoquimioterapia/métodos , Protetores contra Radiação/administração & dosagem , Envelhecimento da Pele/efeitos dos fármacos , Creme para a Pele/administração & dosagem , Administração Cutânea , Idoso , Idoso de 80 Anos ou mais , Medicina Baseada em Evidências , Humanos , Pessoa de Meia-Idade , Envelhecimento da Pele/patologia , Envelhecimento da Pele/fisiologia , Protetores Solares/administração & dosagem , Resultado do TratamentoRESUMO
BACKGROUND: Homogenous pigmentation can be induced by α-melanocyte-stimulating hormone (MSH) homologues. Cosmetically inacceptable pigmentation is mostly located on the face. OBJECTIVES: Although afamelatonide is a prescription drug for the orphan disease erthropoetic protoporphyria, structurally related α-MSH derivatives are available via the internet. Preventive and therapeutical options are necessary for postinflammatory hyperpigmentation, melasma, and lentigines. METHODS: Case reports address activation of dysplastic naevi by melanotan I. Wood's lamp is of some use in analyzing the level of hyperpigmentation. However, no guidelines have been established; thus, a summary of current studies is presented. RESULTS: Melanotan I leads to the activation of dysplastic nevi. The gold standard for hyperpigmentation is triple therapy with hydrochinon, tretinoin, and steroids, which can cause irritation and lead to ochronosis in some individuals. Tyrosinase inhibitors, substances that increase the cell turnover, and plant derivatives are less efficient but more tolerable. CONCLUSIONS: Melanotan I and bleaching creams, which may possibly contain mercury, are dangerous. Hyperpigmentation is best treated using a combination therapy that inhibits melanocyte activity and melanin synthesis, removes melanin, destroys melanin granules, and includes UV protection. Especially in Fitzpatrick skin types IV-VI, cryotherapy and laser are not the first line treatment options due to renewed posttreatment hyperpigmentation.
Assuntos
Terapia Combinada/métodos , Técnicas Cosméticas , Dermatoses Faciais/terapia , Ceratolíticos/uso terapêutico , Fototerapia/métodos , Transtornos da Pigmentação/terapia , Medicina Baseada em Evidências , Humanos , Imunossupressores/uso terapêutico , Monofenol Mono-Oxigenase/antagonistas & inibidores , Preparações Clareadoras de Pele/uso terapêutico , Resultado do TratamentoRESUMO
BACKGROUND: Phlebologic diseases have become extremely common and have major socio-economic impact. However, the percentage of dermatologists working in phlebology appears to be decreasing according to the data of the German Society of Phlebology (DGP). METHODS: To investigate the reasons for this development, we--on behalf of the DGP--sent a questionnaire to 120 German Departments of Dermatology in autumn 2012. RESULTS: In 76 returned questionnaires, the number of physicians with additional fellowship training in phlebology averaged 1.5; the average number of those who fulfill the criteria for training fellows in phlebology was 0.9. In 71.1 % of the departments there was a phlebologist. A special phlebologic outpatient clinic existed in 73.7 % of the departments. Sonography with Doppler (89.5 %) and duplex (86.8 %) was used as the most frequent diagnostic tool. For therapy, compression (94.7 %), sclerotherapy (liquid 78.9 %, foam 63.2 %, catheter 18.4 %), endoluminal thermic procedures (radio wave 28.9 %, laser 17.1 %) and surgery (especially crossectomy and stripping 67.1 %, phlebectomy of tributaries 75 %) were used. The average number of treatments was very heterogenous in the different departments. CONCLUSIONS: Phlebology definitely plays an important role in dermatology. Most departments fulfill the formal criteria for the license to conduct advanced training in phlebology. A wide spectrum of phlebological diagnostic and therapeutic procedures is available.
Assuntos
Dermatologia/estatística & dados numéricos , Departamentos Hospitalares/estatística & dados numéricos , Padrões de Prática Médica/estatística & dados numéricos , Dermatopatias Vasculares/diagnóstico , Dermatopatias Vasculares/terapia , Insuficiência Venosa/diagnóstico , Insuficiência Venosa/terapia , Alemanha/epidemiologia , Humanos , Competência Profissional/estatística & dados numéricos , Dermatopatias Vasculares/epidemiologia , Inquéritos e Questionários , Insuficiência Venosa/epidemiologiaRESUMO
Acne should be treated during pregnancy to prevent worsening, scarring, secondary infection or psychological impairment of the mother. Safe products must be chosen. Systemic tetracycline, doxycycline, minocycline or isotretinoin can not be used. Topical benzoyl peroxide or topical azelaic acid are safe therapeutic options. According to the guidelines, systemic corticosteroids or systemic erythromycin (the latter not in lactation) can be employed beginning in the second trimester for severe flares of acne and should be started in cooperation with the patient's gynecologist. Oral zinc is another option, but not for longer than 3 months. Accessory cosmetic measures may be useful, including mechanical peeling or chemical peeling with glycolic or alpha-hydroxy-acids. In contrast, salicylic acid, trichloracetic acid or phenol peels should not be performed in pregnancy. Camouflage makeup can clearly lower the psychological stress.
Assuntos
Acne Vulgar/terapia , Corticosteroides/administração & dosagem , Peróxido de Benzoíla/administração & dosagem , Cosméticos/administração & dosagem , Ácidos Dicarboxílicos/administração & dosagem , Complicações na Gravidez/terapia , Zinco/administração & dosagem , Administração Oral , Administração Tópica , Feminino , Humanos , GravidezRESUMO
Mitomycin C is an alkylating chemotherapeutic agent which is instilled intravesically to prevent recurrence of superficial bladder carcinomas. After several cycles of mitomycin C, our patient developed a pruritic genital dermatitis and palmar desquamation. Following exclusion of a fungal infection, we performed patch tests using the standard series, the major basic ointment ingredients, disinfectants, and mitomycin C in concentrations of 0.001 to 0.1%; the resulting diagnosis was allergic contact dermatitis due to delayed-type hypersensitivity to mitomycin C. The skin rash rapidly resolved with application of topical steroids, and the intravesical chemotherapy was changed to doxorubicin. Eczematous skin reactions are quite common side effects after intravesical instillation of mitomycin C. In the majority of cases, they are caused by delayed-type hypersensitivity reactions, presumably elicited by hematogenous spread of the allergen, and not by irritation. The sensitization most likely occurs via the bladder mucosa. In order to differentiate between allergic and toxic contact dermatitis, patch tests with the above-mentioned mitomycin C concentrations are useful. In cases of mild allergic contact dermatitis the intravesical chemotherapy might be continued with concomitant topical steroids.
Assuntos
Dermatite de Contato/tratamento farmacológico , Dermatite de Contato/etiologia , Mitomicina/administração & dosagem , Mitomicina/efeitos adversos , Esteroides/administração & dosagem , Administração Intravesical , Administração Tópica , Dermatite de Contato/diagnóstico , Humanos , Masculino , Resultado do TratamentoRESUMO
Pine wood is one of the most used raw products in furniture manufacturing in Europe. High concentrations of colophony and turpentine can be extracted from pine resins. A 45-year-old woman developed a contact dermatitis of the face and hands due to a sensitization to colophony and turpentine after she had bought untreated pine chairs. The increased use of untreated pine in the furniture industry might result in an increase of colophony and turpentine-induced contact allergies. Therefore, the slogan "untreated=harmless" should be considered critically in such cases.
Assuntos
Dermatite Alérgica de Contato/etiologia , Resinas Vegetais/efeitos adversos , Solventes/efeitos adversos , Terebintina/efeitos adversos , Administração Tópica , Corticosteroides/administração & dosagem , Corticosteroides/uso terapêutico , Dermatite Alérgica de Contato/diagnóstico , Dermatite Alérgica de Contato/tratamento farmacológico , Dermatoses Faciais/induzido quimicamente , Dermatoses Faciais/diagnóstico , Feminino , Dermatoses da Mão/induzido quimicamente , Dermatoses da Mão/diagnóstico , Humanos , Decoração de Interiores e Mobiliário , Pessoa de Meia-IdadeRESUMO
One of the common side effects of acetylsalicylic acid (ASA) is the induction of pseudoallergic reactions that range from urticarial wheals to anaphylactic shock. At present there is no reliable detection method available for the diagnosis of ASA-hypersensitivity and its relation to clinical symptoms. The purpose of the present study was to evaluate the functional eicosanoid typing (FET) score taking into account several parameters of the equilibrium between prostaglandins (PG) and peptido-leukotriens (pLT). A total eicosanoid pattern score (TEP) ranging from 0.0 to 3.0, was defined that exhibited significant differences (p Assuntos
Anti-Inflamatórios não Esteroides/efeitos adversos
, Aspirina/efeitos adversos
, Hipersensibilidade a Drogas/diagnóstico
, Eicosanoides/análise
, Urticária/diagnóstico
, Adulto
, Idoso
, Anafilaxia/induzido quimicamente
, Anafilaxia/diagnóstico
, Angioedema/induzido quimicamente
, Angioedema/diagnóstico
, Estudos de Casos e Controles
, Eicosanoides/classificação
, Eicosanoides/metabolismo
, Feminino
, Humanos
, Técnicas Imunoenzimáticas/métodos
, Leucotrienos/análise
, Leucotrienos/metabolismo
, Masculino
, Pessoa de Meia-Idade
, Prostaglandinas/análise
, Prostaglandinas/metabolismo
, Urticária/induzido quimicamente
RESUMO
BACKGROUND: Bullous mastocytosis is an unusual variant of mast cell disease with widespread bullae as the main cutaneous feature induced by mast cell proteases that cause dermoepidermal separation. CASE REPORT: A rare case of diffuse cutaneous bullous mastocytosis with pachydermia and unusually extensive skin folding is described in a 3-week-old girl. The diagnosis was confirmed by immunohistochemistry with Giemsa stain, the naphthol ASD chloroacetate esterase reaction and elevated blood levels for tryptase, histamine in serum and histamine and 1.4-methylimidazol acetic acid in the 24-hour urine. Blood cell count was normal, as were thrombocytosis and leukocytosis. FACS analysis of the bone marrow aspiration material showed 1% mast cells. No c-Kit 816 [Asp-->Val] somatic mutation was found. Systemic involvement of other organs was excluded. DISCUSSION: The prognosis of c-Kit-negative diffuse bullous mastocytosis is not known. Regular blood controls are mandatory, and screening for germ cell ovarian cancer and bone marrow controls should be performed as well.
Assuntos
Pele/patologia , Urticaria Pigmentosa/patologia , Feminino , Humanos , Recém-Nascido , Mutação de Sentido Incorreto , Proteínas Proto-Oncogênicas c-kit/genética , Pele/metabolismo , Urticaria Pigmentosa/genéticaAssuntos
Anticoagulantes/efeitos adversos , Anticoagulantes/uso terapêutico , Heparina/efeitos adversos , Complicações na Gravidez , Sarcoidose/complicações , Trombose/complicações , Adulto , Anticoagulantes/administração & dosagem , Feminino , Hirudinas/administração & dosagem , Humanos , Injeções Subcutâneas , Gravidez , Complicações Cardiovasculares na Gravidez/tratamento farmacológico , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/uso terapêutico , Dermatopatias/induzido quimicamente , Trombose/tratamento farmacológicoRESUMO
BACKGROUND: The external auditory canal cholesteatoma (EACC) is characterized by hyperproliferation of the epithelial and subepithelial tissue. Compared to normal meatal skin, strong expression of FGF-2 and VEGF had previously been detected. Many authors reported that FGF-2 acts via VEGF and is induced by hypoxia. Hypoxia seems to be pivotal for establishing EACC. Therefore, human EACC fibroblasts were investigated by incubating with FGF-2 and determining VEGF. PATIENTS AND METHODS: We harvested fibroblasts from human EACC and normal meatal skin and incubated the fibroblast culture with 50 ng/ml FGF-2 and determined VEGF concentrations after 1-4 days. RESULTS: Compared to untreated fibroblast cultures, there was a significant increase of VEGF concentration (p<0.05). However, there was no significant difference between the proliferation quantities. CONCLUSION: VEGF and FGF-2 are possibly involved in a cascade of growth factor activities, which modulates their concentration in human-derived EACC fibroblast culture. Exogenous FGF-2 increased fibroblast expression for VEGF, which is a major autocrine mediator of FGF-2-induced angiogenesis and proliferation.
Assuntos
Indutores da Angiogênese/análise , Colesteatoma da Orelha Média/patologia , Meato Acústico Externo/patologia , Fibroblastos/patologia , Biópsia , Divisão Celular/fisiologia , Hipóxia Celular/fisiologia , Células Cultivadas , Epitélio/patologia , Fator 2 de Crescimento de Fibroblastos/análise , Humanos , Fator A de Crescimento do Endotélio Vascular/análiseRESUMO
Safe levels of UV exposure and UV protection are the most important measures to protect the skin from epithelial skin cancer and skin aging. This report reviews noninvasive topical methods to counteract skin wrinkling and irregular pigmentation of aging skin. Furthermore, information is provided about the effects of UV protection by using sunscreens and topical antioxidants. The effect of vitamin A acid derivatives, chemical peeling, and bleaching agents is considered. Newly developed substances are presented.
Assuntos
Envelhecimento/efeitos dos fármacos , Fármacos Dermatológicos/administração & dosagem , Transtornos da Pigmentação/prevenção & controle , Envelhecimento da Pele/efeitos dos fármacos , Administração Tópica , Antioxidantes/administração & dosagem , Humanos , Guias de Prática Clínica como Assunto , Padrões de Prática Médica , Protetores Solares/administração & dosagem , Vitamina A/administração & dosagemRESUMO
BACKGROUND AND OBJECTIVES: The efficacy and tolerance of an antiseptic wound powder based on the antibiotic tyrothricin was investigated in a prospective, randomized multicenter trial in patients with posttraumatic and surgical cutaneous lesions. PATIENTS AND METHODS: In 5 centers, 131 male and female patients from 18-85 years were included with posttraumatic or surgical cutaneous lesions with infection or in danger of infection (area > or = 200 mm2). In a double-blind study, tyrothricin (n = 62; 0.1 g tyrothricin per 100 g of vehicle) or placebo powder (n = 69) was applied to the wound twice daily for 9 days. The primary aim was to evaluate the average daily reduction of the radius from the lesion area between the start and end of the randomized treatment (alpha = 0.025; one-sided). Secondly, a wound index (range 0-15) was calculated from the assessments of rubor, crusting, exudation, pain and functional impairment. RESULTS: The treatment groups were comparable at baseline. During randomized treatment, the radius of the lesions was reduced at an average of 0.55 +/- 0.31 mm/day (mean +/- SD) for tyrothricin and 0.47 +/- 0.30 mm/day for placebo (p = 0.016; one-sided; intention-to-treat data set). The wound index decreased at an average of 4.2 +/- 1.7 and 3.3 +/- 1.9 points for tyrothricin and placebo, respectively (p = 0.0048; one-sided). 4 adverse events occurred in each group. A causal relationship with the investigational drug could not be excluded in 3 of the placebo group. CONCLUSION: The results confirm the tendency to an acceleration of wound healing by tyrothricin powder (Tyrosur Powder) in case of infection or danger of infection. A superior efficacy compared to placebo was demonstrated. Due to its good tolerability and the absence of a systemic effects tyrothricin powder is appropriate for the treatment of superficial skin lesions.
Assuntos
Anti-Infecciosos Locais/uso terapêutico , Pele/lesões , Tirotricina/uso terapêutico , Ferimentos e Lesões/tratamento farmacológico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Anti-Infecciosos Locais/administração & dosagem , Anti-Infecciosos Locais/efeitos adversos , Método Duplo-Cego , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pele/microbiologia , Pele/patologia , Infecção da Ferida Cirúrgica/prevenção & controle , Tirotricina/administração & dosagem , Tirotricina/efeitos adversos , Cicatrização/efeitos dos fármacos , Ferimentos e Lesões/microbiologia , Ferimentos e Lesões/patologiaAssuntos
Anticoagulantes/efeitos adversos , Dalteparina/efeitos adversos , Fibrinolíticos/efeitos adversos , Púrpura/diagnóstico , Dermatopatias/induzido quimicamente , Dermatopatias/diagnóstico , Pele/patologia , Idoso , Idoso de 80 Anos ou mais , Diagnóstico Diferencial , Extremidades , Feminino , Humanos , Necrose , Púrpura/induzido quimicamente , Dermatopatias/patologiaRESUMO
There is a wide variety of topical or surgical treatment options for molluscum contagiosum (MC). However, treatment in young or anxious children is difficult, time-consuming and often painful. We studied the topical efficacy and tolerance of imiquimod, a topical immune-response modifier, which stimulates the production of interferon-alpha and other cytokines in children with MC. In an open-label, follow-up trial, imiquimod 5% cream was applied three times a week for 16 weeks to 15 children aged 4-11 years with multiple MC. Nine of 13 children (69%) who completed treatment responded. Two patients (15%) showed a complete remission, and seven (54%) had a partial response, with a remarkable reduction of the MC lesions. Four children (31%) showed stable or progressive disease. In three children (23%) with partial remission, the number of mollusca were considerably reduced, thus avoiding surgical treatment. In general, the treatment was well-tolerated, without systemic side-effects. Local side-effects included erythema (85%), itching (75%), burning sensations (23%) and pain (11%). Three children (23%) discontinued treatment because of local side-effects. The results of this study suggest that imiquimod 5% cream is a useful new treatment option for MC in children, especially in severe cases. The dosing schedule and length of treatment requires further evaluation.
Assuntos
Adjuvantes Imunológicos/uso terapêutico , Aminoquinolinas/uso terapêutico , Molusco Contagioso/tratamento farmacológico , Adjuvantes Imunológicos/efeitos adversos , Aminoquinolinas/efeitos adversos , Criança , Pré-Escolar , Esquema de Medicação , Eritema/induzido quimicamente , Feminino , Seguimentos , Humanos , Imiquimode , Masculino , Pomadas , Dor/induzido quimicamente , Prurido/induzido quimicamenteRESUMO
OBJECTIVE: PAF-R (platelet activating factor-receptor) has been found on human keratinocytes to bind PAF, a proinflammatory phospholipid. We aimed to study PAF-R in a range of dermal cell lines and in samples of normal and psoriatic human skin to learn about its further role in humans. METHODS: PAF-R was labeled immunocytochemically, histochemically and additionally studied with western blotting in human keratinocytes, human fibroblasts, embryonal keratinocytes, tumor cell lines and samples of normal and psoriatic human skin. RESULTS: Keratinocytes from adult and embryonal epidermis of the 20th week of pregnancy showed a low level of labeling for PAF-R, but 3 +/- 0.05% of plantar keratinocytes from adults were positive as were 4.2 +/- 0.05% of embryonal plantar keratinocytes from the 21st week of pregnancy. In fibroblasts from adult and embryonal epidermis the protein was expressed at low levels. Western blotting revealed PAF-R positive bands at 67 k.Da in normal human skin and psoriasis, in psoriasis additionally at 45 k.Da. A 68 k.Da band was found in the colon cancer line HT 29 (control), and HaCaT cells, in embryonal keratinocytes additionally at 116 k.Da. CONCLUSIONS: PAF-R seems not to be important for embryonal or adult fibroblasts. In embryonal keratinocytes it is turned on after the 21st pregnancy week in a few cells seen as a band of 67 k.Da and at 116 k.Da, the latter is not found in adult keratinocytes. An additional 45 k.Da band of PAF-R was found in psoriasis that might stand for a truncated receptor. In the epithelial tumor cell line HaCaT and the HT29 colon cancer cell line PAF-R characterizes the anti-apoptotic effect of this receptor propagating tumor proliferation.
Assuntos
Embrião de Mamíferos/metabolismo , Epiderme/metabolismo , Inflamação/metabolismo , Glicoproteínas da Membrana de Plaquetas/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Adulto , Western Blotting , Linhagem Celular Tumoral , Células Cultivadas , Embrião de Mamíferos/citologia , Feminino , Fibroblastos/metabolismo , Humanos , Imuno-Histoquímica , Inflamação/patologia , Queratinócitos/metabolismo , Fosfolipídeos/metabolismo , Gravidez , Psoríase/metabolismo , Valores de Referência , Glândulas Sudoríparas/metabolismoRESUMO
BACKGROUND AND AIM: Tea tree oil, a distillation product of the Australian tea tree (Melalence alternitolia) is increasingly used as an alternative remedy for various dermatological diseases. Tea tree oil contains several allergenic monoterpenes and sesquiterpenes. In this multicenter study it was evaluated, whether the increasing use of tea tree oil has lead to an increased frequency of sensitization in Germany and Austria which would justify its inclusion into the standard series. PATIENTS AND METHOD: For patch testing a standardized tea tree oil was used, dissolved 5% in diethylphtalate (DEP). Consecutive patients of 11 dermatological departments in Germany and Austria were tested. Readings were taken on day 2 and 3 according to the guidelines of the German Contact Dermatitis Research Group (DKG). RESULTS: 5% tea tree oil was positive in 36/3375 patients (1.1%). Sensitization frequencies showed great regional variations and ranged from 2.3% (Dortmund), 1.7% (Buxtehude), 1.1% (Essen), 0.7% (Graz), to 0% (Berlin, Vienna). 14/36 patients (38.9%) also showed a positive patch test reaction to oil of turpentine. CONCLUSION: Our results show that tea tree oil is an important contact allergen for some centers. It should be tested, if medical history suggests its previous use. Considering the great regional differences in frequencies of sensitization its inclusion into the standard series is not recommended yet.